Skip to main content
Signal8

Kynam Capital Management, LP

Kynam Capital Management, LP is an Investment Adviser institutional filer with the SEC under CIK 1907884, reporting 32 portfolio positions, with 20 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in Kynam Capital Management, LP's most recent 13F filing, ranked by reported market value.

  1. CELLDEX THERAPEUTICS INC NEW (CLDX)
  2. SYNDAX PHARMACEUTICALS INC (SNDX)
  3. VAXCYTE INC (PCVX)
  4. COGENT BIOSCIENCES INC (COGT)
  5. VERA THERAPEUTICS INC (VERA)
  6. VIRIDIAN THERAPEUTICS INC (VRDN)
  7. TRAVERE THERAPEUTICS INC (TVTX)
  8. BEAM THERAPEUTICS INC (BEAM)
  9. UROGEN PHARMA LTD (URGN)
  10. LEGEND BIOTECH CORP (LEGN)
/